Funding Rounds
Asceneuron

Asceneuron Series C (2024, $100M)

Asceneuron

Developer of treatments for neurodegenerative diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $100.00M

Investors